Advertisement
Advertisement
ONC
BeOne Medicines Ltd. - ADR
376.37
USDSponsored
+4.39
+1.18%
Aug 25, 15:59 UTC -4
Closed
Pre-Market
379.07
+2.70
+0.72%
ONC Earnings Reports
Positive Surprise Ratio
ONC beat 5 of 17 last estimates.
29%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$12.77B
/$1.09
Implied change from Q2 26 (Revenue/ EPS)
+10.96%
/-92.12%
Implied change from Q3 25 (Revenue/ EPS)
+26.35%
/+91.23%
BeOne Medicines Ltd. - ADR earnings per share and revenue
On Aug 05, 2026, ONC reported earnings of 13.83 USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 11.51 billion, compared to an expected --, with a --% difference. The market reacted with a +1.40% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 1.09 USD, with revenue projected to reach 12.77 billion USD, implying an decrease of -92.12% EPS, and increase of 10.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nektar Therapeutics
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$2.02
Actual
-$1.23
Surprise
+39.24%
Altimmune, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+14.22%
ARS Pharmaceuticals, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.50
Actual
-$0.63
Surprise
-25.40%
Journey Medical Corporation Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.01
Surprise
+56.33%
MediWound Ltd.
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.77
Actual
-$0.77
Surprise
+0.89%
PolyPid Ltd. Ordinary Shares
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.35
Surprise
+9.28%
Talphera, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.06
Actual
-$0.06
Surprise
+11.76%
Karyopharm Therapeutics Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.30
Actual
-$2.31
Surprise
-78.16%
Vyome Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.19
Actual
-$0.10
Surprise
+48.40%
CDT Equity Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-Actual
-$8.71
Surprise
-
FAQ
What were BeOne Medicines Ltd. - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, BeOne Medicines Ltd. - ADR reported EPS of $13.83, missing estimates by --, and revenue of $11.51B, -- -- expectations.
How did the market react to BeOne Medicines Ltd. - ADR's Q2 2026 earnings?
The stock price moved up 1.4%, changed from $323.01 before the earnings release to $327.53 the day after.
When is BeOne Medicines Ltd. - ADR expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for BeOne Medicines Ltd. - ADR's next earnings report?
Based on --
analysts, BeOne Medicines Ltd. - ADR is expected to report EPS of $1.09 and revenue of $12.77B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement